Dr. Antoni Esteve i Subirana begins his pharmaceutical dream in a small pharmacy in Manresa (Barcelona-Spain), with a creative, innovative and enterprising spirit.
The company's first vitamin specialties are developed: Esterocal and Esterosol.
We synthesize the first neoarsenobenzene in Spain, Neo-Spirol.
We synthesize the first sulfonamide in Spain.
We expand, moving to Barcelona and into a new headquarters
For the first time in Spain, Esteve produces penicillin.
Dr. Alexander Fleming, discoverer of penicillin and Nobel laureate in Medicine, visits ESTEVE.
We start to expand internationally by exporting antihemorrhagic 101 (1954) and etamsylate (1959).
Esteve Química is founded, and the first chemical plant is built in Barcelona.
Our internal research yields our first NCE (new chemical entity): Calcium Dobesilate. It is currently used on every continent.
As part of a joint venture with PUIG, ISDIN, a company specializing in dermatology, is founded.
We open the new Esteve Química plant in Celrà (Girona), with production activities commencing in 1984.
We create the OTC division.
Two new industrial plants are added to the group, one to manufacture pharmaceuticals, in Martorelles (Barcelona), and another to make active ingredients, in Mexico.
We expand, with a second plant in Mexico, two partnerships with the Huadong group in China and the acquisition of a plant in Banyeres del Penedés (Barcelona).
Pensa is created, a subsidiary of the group specializing in marketing generic medicines.
We start a joint venture with Teijin Pharma called Esteve Teijin Healthcare. Also in 2009, we acquire Breckenridge Pharmaceuticals in the USA.
We launch optimized Omeprazole, a new innovative formulation.
Industrial Spray Drying and HPAPI in Spain.
The various ESTEVE offices in Barcelona move to Esteve Tower, which becomes the group's headquarters. It's the start of a new era in how we work.
ESTEVE acquires Riemser, a pharma Company with affiliates in Germany, the UK and France. Divestment of Generics business (Pensa)
FDA approves Seglentis®, an innovative co-crystal form of celecoxib (an anti-inflammatory) and tramadol (an analgesic) for the treatment of acute pain in adults.
Acquisition of a manufacturing plant in Spain (Lliçà de Vall) in line with ESTEVE's expansion strategy.